Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Seminoma × ARQ 197 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Hepatocellular 4 Carcinoma, Renal Cell 3 Solid Tumors 2 Melanoma 2 Carcinoma 2 Breast Neoplasms 2 Stomach Neoplasms 1 Seminoma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Fibrosis 1 Colorectal Neoplasms 1

Interventions

Imatinib Mesylate 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01055067 2021-04-06

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Daiichi Sankyo

Phase 2 Terminated

27 enrolled 6 charts

Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡